[1. N. Ahmad, J. K. Ferris, E. Gooden and T. Abell, Making a case for domperidone in the treatment of gastrointestinal motility disorders, Curr. Opin. Pharmacol. 6 (2006) 571-576.10.1016/j.coph.2006.07.004]Search in Google Scholar
[2. S. C. Reddymasu, I. Soykan and R. W. McCallum, Domperidone: review of pharmacology and clinical applications in gastroenterology, Am. J. Gastroenterol. 102 (2007) 2036-2045.]Search in Google Scholar
[3. S. A. Charman, W. N. Charman, M. C. Rogge, T. D. Wilson, F. J. Dutko and C. W. Pouton, Self- -emulsifying drug delivery systems: formulation and biopharmaceutics evaluation of an investigational lipophilic compound, Pharm. Res. 9 (1992) 87-93; DOI: 10.1023/A:1018987928936.10.1023/A:1018987928936]Search in Google Scholar
[4. D. Q. M. Craig, H. S. R. Lievens, K. G. Pitt and D. E. Storey, An investigation into the physicochemical properties of self-emulsifying systems using low frequency dielectric spectroscopy, surface tension measurements and particle size analysis, Int. J. Pharm. 96 (1993) 147-155; DOI: 10.1016/ 0378-5173(93)90222-2.10.1016/0378-5173(93)90222-2]Search in Google Scholar
[5. N. H. Shah, M. T. Carvajal, C. I. Patel, M. H. Infeld and A. W. Malick, Self-emulsifying drug delivery systems (SEDDS) with polyglycolysed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs, Int. J. Pharm. 106 (1994) 15-23; DOI: 10.1016/0378-5173(94)90271-2.10.1016/0378-5173(94)90271-2]Search in Google Scholar
[6. R. N. Gursoy and S. Benita, Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs, Biomed. Pharmacother. 58 (2004) 173-182.10.1016/j.biopha.2004.02.001]Search in Google Scholar
[7. C. W. Pouton, Formulation of self-emulsifying drug delivery systems, Adv. Drug Deliver. Rev. 25 (1997) 47-58; DOI: 10.1016/S0169-409X(96)00490-5.10.1016/S0169-409X(96)00490-5]Search in Google Scholar
[8. C. W. Pouton, Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system, Eur. J. Pharm. Sci.29 (2006) 278-287; DOI: 10.1016/j.ejps.2006.04.016.10.1016/j.ejps.2006.04.016]Search in Google Scholar
[9. T. Gershanik and S. Benita, Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs, Eur. J. Pharm. Sci. Biopharm. 50 (2000) 179-188.10.1016/S0939-6411(00)00089-8]Search in Google Scholar
[10. P. P. Constantinides, Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects, Pharm. Res. 12 (1995) 1561-1572.]Search in Google Scholar
[11. C. W. Pouton, Lipid formulations for oral administration of drugs: nonemulsifying, self-emulsifying and self-microemulsifying drug delivery systems, Eur. J. Pharm. Sci. 11 (2000) S93-S98.10.1016/S0928-0987(00)00167-6]Search in Google Scholar
[12. B. K. Kang, J. S. Lee, S. K. Chon, S. Y. Jeong, S. H. Yuk, G. Khang, H. B. Lee and S. H. Cho, Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs, Int. J. Pharm. 274 (2004) 65-73; DOI: 10.1016/j.ijpharm.2003. 12.028.]Search in Google Scholar
[13. R. P. Ashok and R. V. Pradeep, Preparation and evaluation of SMEDDS (Self-microemulsifying drug delivery system) containing fenofibrate, AAPS J. 9 (2007) E 344-352; DOI: 10.1208/aapsj0903041.10.1208/aapsj0903041275148618170981]Search in Google Scholar
[14. M. B. Klimkowska, K. Zywiec, A. Poteulas and M. Szutowski, Impact of the changes in P-glycoprotein activity on domperidone pharmacokinetics in rat plasma, Pharmacol. Rep. 59 (2007) 752-756.]Search in Google Scholar
[15. T. R. Kommuru, B. Gurley, M. A. Khan and I. K. Reddy, Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment, Int. J. Pharm. 212 (2001) 233-246; DOI: 10.1016/S0378-5173(00)00614-1.10.1016/S0378-5173(00)00614-1]Search in Google Scholar
[16. C. Shengmiao, Z. Chunshun, C. Dawei and H. Zhonggui, Self-microemulsifying drug delivery systems for improving in vitro dissolution and oral absorption of Pueraria lobata isoflavone, DrugDev. Ind. Pharm. 31 (2005) 349-356.10.1081/DDC-54309]Search in Google Scholar
[17. W. Lanlan, S. Peinan, N. Shufang and P. Weisan, Preparation and evaluation of SEDDS and SMEDDS containing carvedilol, Drug Dev. Ind. Pharm. 31 (2005) 785-794; DOI: 10.1080/03639040500216428.10.1080/03639040500216428]Search in Google Scholar
[18. K. Prabhakar, S. M. Afzal, G. Surendar and V. Kishan, Brain specific delivery of pegylated indinavir submicron lipid emulsions, Eur. J. Pharm. Sci. 42 (2011) 423-432.10.1016/j.ejps.2011.01.008]Search in Google Scholar
[19. G. M. Eccleston, Microemulsions, in Encyclopedia of Pharmaceutical Technology (Eds. S. Swarbrick and J. C. Boylan), Marcel Dekker, New York 1992, pp. 375-421.]Search in Google Scholar
[20. W. N. Charman and V. J. Stella, Transport of lipophilic molecules by the intestinal lymphatic system, Adv. Drug Deliv. Rev. 7 (1991) 1-14; DOI: 10.1016/0169-409X(91)90046-F.10.1016/0169-409X(91)90046-F]Search in Google Scholar
[21. E. S. Swenson and W. J. Curatolo, Means to enhance penetration, Adv. Drug Deliv. Rev. 8 (1992) 39-92; DOI: 10.1016/0169-409X(92)90015-I.10.1016/0169-409X(92)90015-I]Search in Google Scholar
[22. W. Wei, W. Yang and Q. Li, Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system, Eur. J. Pharm. Biopharm. 63 (2006) 288-94; DOI: 10.1016/j.ejpb.2005.12.005. 10.1016/j.ejpb.2005.12.00516527467]Search in Google Scholar